Market News

Unveiling Immunome’s Triumph in Q4 2023 Earnings Report Unveiling Immunome’s Triumph in Q4 2023 Earnings Report

by Ron Finklestien

Published On: March 29, 2024 1:04 am

IMNM stock - IMNM Stock Earnings: Immunome Beats EPS, Beats Revenue for Q4 2023

Source: iQoncept / Shutterstock

Immunome (NASDAQ:IMNM) recently revealed its performance for the fourth quarter of 2023.

Surpassing expectations, Immunome reported earnings per share of -15 cents, significantly beating the analyst estimate of -28 cents.
The company’s revenue stood at a remarkable $3.83 million.
This figure reflected a striking 84.83% increase over the analyst estimate of $2.07 million.

InvestorPlace Earnings combines data from TradeSmith to automate the coverage of quarterly earnings reports. It provides concise summaries of key financial indicators such as earnings per share and revenue, comparing actual figures with analyst predictions. By eliminating human intervention, we bring the freshest data to our readers promptly. For any feedback or corrections, reach out to us at [email protected].

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/imnm-stock-earnings-immunome-for-q4-of-2023/.